GUT:口服抗生素与结直肠肿瘤风险差异

2019-08-21 MedSci MedSci原创

研究发现口服抗生素会增加结肠癌风险,但降低了直肠癌风险,这种效应的异质性可能提示肠道微生物区系和下肠道癌变机制的差异

微生物群失调易导致直肠癌(CRC),近日研究人员评估口服抗生素使用与CRC风险的关系。

研究人员考察1989至2012年间相关资料,采用临床实践研究数据进行了一项匹配的病例对照研究。

总计28980例CRC病例和137 077例对照。口服抗生素直肠癌风险增加相关,但其影响因解剖位置而异。抗生素的使用以剂量依赖性的方式增加结肠癌风险。即使在最少使用剂量后也可以观察,在近端结肠和使用具有抗厌氧活性的抗生素时风险最大。相反,抗生素使用与直肠癌呈负相关,特别是抗生素暴露时间>60天(调整OR值为0.85)人群。青霉素,特别是氨苄西林/阿莫西林增加了结肠癌的风险(aOR =1.09),而四环素则降低了直肠癌的风险(aOR =0.90)。在诊断前10年(aOR =1.17)即可发现抗生素与癌症的关联。

研究发现口服抗生素会增加结肠癌风险,但降低了直肠癌风险,这种效应的异质性可能提示肠道微生物区系和下肠道癌变机制的差异。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2026043, encodeId=83df202604392, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Dec 22 03:49:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928691, encodeId=4ee8192869103, content=<a href='/topic/show?id=7257e24943e' target=_blank style='color:#2F92EE;'>#直肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72494, encryptionId=7257e24943e, topicName=直肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Wed Oct 09 00:49:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417322, encodeId=3c14141e32222, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453292, encodeId=1a3d1453292cb, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487788, encodeId=dc35148e78814, content=<a href='/topic/show?id=f364e871840' target=_blank style='color:#2F92EE;'>#结直肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78718, encryptionId=f364e871840, topicName=结直肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78398366026, createdName=tamgche, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2026043, encodeId=83df202604392, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Dec 22 03:49:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928691, encodeId=4ee8192869103, content=<a href='/topic/show?id=7257e24943e' target=_blank style='color:#2F92EE;'>#直肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72494, encryptionId=7257e24943e, topicName=直肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Wed Oct 09 00:49:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417322, encodeId=3c14141e32222, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453292, encodeId=1a3d1453292cb, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487788, encodeId=dc35148e78814, content=<a href='/topic/show?id=f364e871840' target=_blank style='color:#2F92EE;'>#结直肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78718, encryptionId=f364e871840, topicName=结直肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78398366026, createdName=tamgche, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2026043, encodeId=83df202604392, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Dec 22 03:49:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928691, encodeId=4ee8192869103, content=<a href='/topic/show?id=7257e24943e' target=_blank style='color:#2F92EE;'>#直肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72494, encryptionId=7257e24943e, topicName=直肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Wed Oct 09 00:49:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417322, encodeId=3c14141e32222, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453292, encodeId=1a3d1453292cb, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487788, encodeId=dc35148e78814, content=<a href='/topic/show?id=f364e871840' target=_blank style='color:#2F92EE;'>#结直肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78718, encryptionId=f364e871840, topicName=结直肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78398366026, createdName=tamgche, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2026043, encodeId=83df202604392, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Dec 22 03:49:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928691, encodeId=4ee8192869103, content=<a href='/topic/show?id=7257e24943e' target=_blank style='color:#2F92EE;'>#直肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72494, encryptionId=7257e24943e, topicName=直肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Wed Oct 09 00:49:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417322, encodeId=3c14141e32222, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453292, encodeId=1a3d1453292cb, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487788, encodeId=dc35148e78814, content=<a href='/topic/show?id=f364e871840' target=_blank style='color:#2F92EE;'>#结直肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78718, encryptionId=f364e871840, topicName=结直肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78398366026, createdName=tamgche, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2026043, encodeId=83df202604392, content=<a href='/topic/show?id=c3048314322' target=_blank style='color:#2F92EE;'>#肿瘤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83143, encryptionId=c3048314322, topicName=肿瘤风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Dec 22 03:49:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928691, encodeId=4ee8192869103, content=<a href='/topic/show?id=7257e24943e' target=_blank style='color:#2F92EE;'>#直肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72494, encryptionId=7257e24943e, topicName=直肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=bnjfy, createdTime=Wed Oct 09 00:49:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417322, encodeId=3c14141e32222, content=<a href='/topic/show?id=625a3821ebe' target=_blank style='color:#2F92EE;'>#口服抗生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38217, encryptionId=625a3821ebe, topicName=口服抗生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89f83256788, createdName=dinorsor525, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453292, encodeId=1a3d1453292cb, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487788, encodeId=dc35148e78814, content=<a href='/topic/show?id=f364e871840' target=_blank style='color:#2F92EE;'>#结直肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78718, encryptionId=f364e871840, topicName=结直肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78398366026, createdName=tamgche, createdTime=Fri Aug 23 09:49:00 CST 2019, time=2019-08-23, status=1, ipAttribution=)]

相关资讯

Blood:抗生素可抑制皮肤T细胞淋巴瘤的活性

已有研究表明,CD4 T细胞对金黄色葡萄球菌(SA)的反应可能在无意中促进了皮肤癌和皮肤T细胞淋巴瘤(CTCL)模型的肿瘤进展。在本回顾性研究中,研究人员对短暂的抗生素治疗对肿瘤细胞和疾病活动的影响进行研究。

使用头孢类抗生素期间切勿饮酒:大伯出院当天又因休克急诊

杭州66岁的陈大伯(化名)上午挂完盐水出院,当天午饭喝了一两白酒庆祝病愈,不想下午又因使用头孢类抗生素期间饮酒造成过敏反应导致休克被送回了医院。“使用头孢类抗生素期间,以及停药后数日应禁止饮酒,包括吃含酒食品。”8月5日,杭州市红十字会医院急诊科副主任医师金璐告诉澎湃新闻(www.thepaper.cn)。陈大伯平时爱喝点酒。前阵子,他因肺炎住进杭州市红会医院,2日中午挂完盐水出院。为庆祝病愈,老

Blood:厉害了,抗生素还能治疗淋巴瘤

近日,丹麦哥本哈根大学和奥胡斯大学等机构带来了一项激动人心的研究成果。他们发现,抗生素能够抑制罕见淋巴瘤患者皮肤上的癌细胞。

Ann Intern Med:警惕!念珠菌:一种新型的全球性耐药真菌

念珠菌正在成为一种新型的全球性耐药真菌。

Nat Commun:清华饶燏组推动更强抗生素的全合成研究

随着耐甲氧西林金黄色葡萄球菌以及耐万古霉素粪肠球菌等多重耐药致命病原微生物的不断加重,2014年,世界卫生组织宣布人类进入后抗生素时代。换言之,从这个世纪开始,人类可能死于普通的感染或者小型创伤。同时,近30年来没有主要的新型抗生素被发现,人类开发新型抗生素迫在眉睫。2015年,Lewis等人发现了一种新型抗生素并命名为Teixobactin。其杀死小鼠机体中致命耐药细菌的速度与现存抗生素的速度相

Blood:抗生素抑制皮肤T细胞淋巴瘤患者肿瘤和疾病活动

总之,该研究提供了新的证据表明积极的抗生素治疗可抑制皮损中的恶性T细胞。因此,该研究提供了治疗晚期CTCL患者SA的新理论基础。